Table 3.
Therapy | Total |
---|---|
Vasoactive infusions* | 314 (55) |
Dopamine† | 102 (32) |
Dobutamine† | 20 (6) |
Epinephrine† | 134 (43) |
Norepinephrine† | 133 (42) |
Vasopressin† | 31 (10) |
Phenylephrine† | 2 (<1) |
Milrinone† | 95 (30) |
Vasodilator†‡ | 9 (3) |
Invasive mechanical ventilation | 421 (74) |
Corticosteroids | 242 (45) |
Albumin | 135 (24) |
Synthetic colloid | 22 (4) |
Blood products§ | 232 (41) |
Nutrition, enteral | 331 (58) |
Nutrition, parenteral | 221 (39) |
Gastric stress ulcer prophylaxis | 445 (78) |
Insulin║ | 57 (10) |
G/GM-CSF | 23 (4) |
IVIG | 38 (7) |
RRT¶ | 81 (14) |
Plasma exchange | 5 (1) |
ECMO | 30 (5) |
Definition of abbreviations: ECMO = extracorporeal membrane oxygenation; G/GM-CSF = granulocyte/granulocyte–monocyte colony–stimulating factor; IVIG = intravenous immunoglobulin; RRT = renal replacement therapy.
Data are presented as n (%).
Includes dopamine >5 μg/kg/min, dobutamine >5 μg/kg/min, or any dose of epinephrine, norepinephrine, vasopressin, phenylephrine, milrinone, levosimendan, or a vasodilator.
Denominator is the number of patients receiving any vasoactive infusion (n = 314).
Vasodilators include nitroprusside, nitroglycerin, and nicardipine.
Includes packed red blood cells, platelets, fresh frozen plasma, cryoprecipitate, granulocytes, and whole blood.
Includes intravenous insulin by continuous infusion only.
Includes hemodialysis, all continuous renal replacement modalities, and peritoneal dialysis.